
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-de... Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a low-dose interleukin 2 Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.8399 | 12.6111111111 | 6.66 | 8.29 | 6.2732 | 131598 | 7.04086638 | CS |
4 | 0.4099 | 5.78138222849 | 7.09 | 8.29 | 5.805 | 121313 | 6.59770248 | CS |
12 | 1.6199 | 27.5493197279 | 5.88 | 8.29 | 5.07 | 85022 | 6.29095213 | CS |
26 | 1.4199 | 23.3536184211 | 6.08 | 10.24 | 5.07 | 84479 | 6.83053894 | CS |
52 | -1.9801 | -20.8871308017 | 9.48 | 10.6899 | 4.75 | 74742 | 7.4134386 | CS |
156 | 2.7499 | 57.8926315789 | 4.75 | 10.6899 | 3.21 | 69902 | 6.44775771 | CS |
260 | 2.7499 | 57.8926315789 | 4.75 | 10.6899 | 3.21 | 69902 | 6.44775771 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales